Overview
- 226 inspections across 198 sites are on record.
- 210 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-18.
At a glance
Inspections
226
Sites
198
Observations
210
Career since
Jul 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Dr. Michael Montana, M.D. | 18 Jun 2026 | Human Drugs | |
| Jiangsu Center for Safety Evaluation of Drugs | 3 Apr 2026 | Human Drugs | On file |
| Hubei Topgene Xinsheng Biotechnology Co., Ltd. | 27 Mar 2026 | Human Drugs | |
| Sanjaya Gupta, MD | 6 Feb 2026 | Medical Devices & Rad Health | |
| University Of Mo At KC Hlth Science IRB | 21 Nov 2025 | Medical Devices & Rad Health |
Sites inspected
Dr. Michael Montana, M.D.St. Louis, United States1 insp.
Jiangsu Center for Safety Evaluation of DrugsNanjing, China1 insp.
Hubei Topgene Xinsheng Biotechnology Co., Ltd.Wuhan, China1 insp.
Sanjaya Gupta, MDKansas City, United States1 insp.
University Of Mo At KC Hlth Science IRBKansas City, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Zhou Chen8 shared
Audra J Lenhart8 shared
James J Houlihan8 shared
William F Lagud7 shared
Mark J Seaton6 shared
Arthur G Hurst5 shared
Lori Gioia5 shared
Vickie J Kanion5 shared
Jason D Tenney4 shared
Erin C Dugan4 shared
Full investigator report
Get the verbatim findings behind Carmen Y Fisher's 210 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site